Rang	Name	Position
1	Prof. Niels C. Riedemann M.D., Ph.D.	Co-Founder, CEO & Executive Director
2	Prof. Renfeng Guo M.D.	Co-Founder, Chief Scientific Officer & Executive Director
3	Dr. Thomas Taapken Ph.D.	Chief Financial Officer
4	Ms. Derval O'Carroll	Senior VP and Global Head of Regulatory Affairs & Compliance
5	Mr. Jan Medina CFA	Head of Investor Relations & VP
6	Mr. Christian Schmid	VP and Head of Legal Affairs & General Counsel
7	Dr. Maria Habel PH.D.	VP, Head of Preclinical R&D and QC
8	Mr. Kofi Boaten	VP and Head of Supply Quality & Clinical Trial Supplies
9	Mr. Peter Hurt Ph.D.	Senior Director and Head of Drug Safety & Pharmacovigiliance
10	Mr. Daniel Vetter	Senior Director & Head of IT

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Suvretta Capital Management, LLC	15,56%	40,59 Mio. USD
2	TCG Crossover Management, LLC	9,84%	25,67 Mio. USD
3	FMR Inc	5,54%	14,45 Mio. USD
4	COMMODORE CAPITAL LP	4,95%	12,92 Mio. USD
5	Kalehua Capital Management LLC	3,93%	10,26 Mio. USD
6	Spruce Street Capital LP	3,63%	9,47 Mio. USD
7	Farallon Capital Management, L.L.C.	2,26%	5,89 Mio. USD
8	683 Capital Management LLC	2,25%	5,87 Mio. USD
9	StemPoint Capital LP	2,19%	5,71 Mio. USD
10	Great Point Partners LLC	2,07%	5,39 Mio. USD
11	ADAR1 Capital Management LLC	2,04%	5,31 Mio. USD
12	Ameriprise Financial Inc	1,75%	4,55 Mio. USD
13	Woodline Partners LP	1,43%	3,73 Mio. USD
14	Squadron Capital Management LLC	1,36%	3,54 Mio. USD
15	Eversept Partners, LP	0,88%	2,31 Mio. USD
16	Franklin Templeton Inc	0,70%	1,83 Mio. USD
17	Morgan Stanley - Brokerage Accounts	0,62%	1,62 Mio. USD
18	Jefferies Financial Group Inc	0,53%	1,37 Mio. USD
19	Marshall Wace Asset Management Ltd	0,48%	1,26 Mio. USD
20	Millennium Management LLC	0,38%	1,00 Mio. USD